858P Exploring antigen presentation (AP) and Wnt/β-Catenin (Wnt) pathway alterations as predictors of immune checkpoint inhibitors (ICI) resistance in patients (pts) with microsatellite instable (MSI) and microsatellite stable (MSS) metastatic colorectal cancer (mCRC) | Publicación